The dissapointment continues. Can we survive this or this isit? I wonder how much the company's intellectual property is worth?

The only way I can see us being saved is an acquisition by another pharmaceutical company or a super cheap PP in which TO and his insiders fund the company's future. They have no cash to hire a new CEO so it will be up to them to keep this co. alive.